Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Pyxis Oncology Acquires Apexigen
Pyxis Oncology announced on May 24 that it acquired Apexigen, Inc. for $16 million. Founded in 2010, Apexigen, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology. Pyxis Oncology is building a differentiated portfolio of biologics, including antibody-drug conjugates and immunotherapies. It is funded by the Longwood Fund, a Boston-based venture capital firm. This acquisition was announced nearly a year after Apexigen went public by a merger with Brookline Capital Acquisition Corp. According to data captured in the LevinPro HC database, this acquisition represents the 61st... Read More »
GraceMed Acquires Canadian Dermatology Centre
GraceMed announced on May 23 that it purchased the Canadian Dermatology Centre for an undisclosed price. Canadian Dermatology Centre is a Toronto-based dermatology clinic that also provides plastic surgery services. It was founded by Dr. Renita Ahluwalia and Dr. Quinton Chivers and has a total of eight providers on staff, according to its website. GraceMed is a leading North American-based dermatology and plastic surgery platform. Per its website, GraceMed operates out of 11 locations in Ontario, Canada. The acquisition of the Canadian Dermatology Centre is part of GraceMed’s strategy to expand its presence across North America, providing greater access to care for patients. ... Read More »
NewSpring-Backed Patheous Health Acquires Carolina Speech Pathology
Patheous Health, backed by private equity firm NewSpring Capital, announced on May 24 its acquisition of Carolina Speech Pathology for an undisclosed price. This deal expands the company’s mobile dysphagia imaging and education service to 18 states, according to the press release. This is Patheous Health’s second acquisition since April 2020, when the company acquired MBS Envision, a leading innovator in feeding and swallow health for diagnostics and therapeutics. The deal also marks the 31st Behavioral Health Care deal of 2023, according to data captured in the LevinPro HC database. Since 1996, Carolina Speech Pathology has been providing mobile fiberoptic endoscopic... Read More »
Florence Acquires Virtual Care Provider Zipnosis
New York-based Florence Labs announced on May 24 its acquisition of Minneapolis-based Zipnosis. Zipnosis is a 60-person health tech company that offers a white-labeled virtual care solution that uses asynchronous telemedicine to connect patients with local board-certified physicians. Florence Labs is a health tech company that works with health systems and provider groups to maximize clinical capacity and reduce administrative burden. Florence Labs was founded in 2021 by Aniq Rahman. Through this acquisition, Florence will broaden its product offerings with synchronous and asynchronous virtual care and further their mission to create a consumer-centric interface that engages patients at... Read More »
Mercy Iowa City Acquires OB-GYN Associates of Iowa City & Coralville
Mercy Iowa City announced on May 17 that it acquired OB-GYN Associates of Iowa City & Coralville. According to its website, OB-GYN Associates of Iowa City & Coralville has four physicians and two nurses on staff. It is in Coralville, Iowa. Mercy Iowa City’s medical staff is composed of more than 250 doctors representing all major medical specialties and most subspecialties. Its hospitals have more than 190 acute care beds, 25 outpatient surgery rooms and 23 bed nurseries. Mercy Iowa City’s birthing center has five labor and delivery suites, a dedicated C-section suite and a pediatric hospitalist team. More than 800 babies are born at Mercy Iowa City each year. The staff... Read More »
Intelligent Medical Objects Announces the Acquisition of Melax Technologies
Intelligent Medical Objects (IMO) announced that it has acquired Melax Technologies for an undisclosed price. According to data captured in the LevinPro HC database, this acquisition represents the 110th eHealth transaction of the year, and the 18th in the analytics specialty. Melax Technologies is a healthcare data analytics and business intelligence company focused on Natural Language Processing that provides healthcare organizations with actionable insights into clinical and financial performance. The company is trusted by more than 650 healthcare organizations. Founded in 1994, IMO is a healthcare data enablement company that provides clinical terminology management and data quality... Read More »
Hospital Market Status & Review: Spring 2023 Update
As we approach the halfway point of 2023, we thought it’d be worthwhile to examine the state of the hospital M&A market so far. Through mid-May, strategic buyers and investors announced 30 hospital deals, 16 of which were in the first quarter, according to data captured in the LevinPro HC database. Considering the number of mergers already in the letter-of-intent stage, deal activity is on pace to beat the volume from 2022. Health systems and hospitals were battered with headwinds in 2022, such as staffing issues and operating expenses, forcing hospitals to partner with a more extensive system or network. But another challenge has been competing in the outpatient care market, which has... Read More »
Bavarian Nordic Closes Acquisition of Emergent BioSolutions’ Travel Health Business
Gaithersburg, Maryland-based Emergent BioSolutions Inc., a specialty biopharmaceutical company, announced that it closed on the sale of its portfolio of travel vaccines to Bavarian Nordic. The transaction was initially announced on February 15, 2023. The portfolio includes Vivotif and Vaxchora, which prevent typhoid fever and cholera, respectively. Emergent BioSolutions is also selling a Phase III vaccine candidate for the prevention of Chikungunya virus. Emergent received $270 million and may receive up to an additional $110 million in potential future milestone payments. Wells Fargo Securities, LLC served as financial advisor, and Barnes & Thornburg LLP served as legal counsel... Read More »
Amulet Capital Partners acquires Alliance Clinical Network
Amulet Capital Partners announced on May 22 its acquisition of Alliance Clinical Network (ACN) for an undisclosed price. According to data captured in the LevinPro HC database, this acquisition marks the 11th clinical trials transaction of the year. Headquartered in Dallas, Texas, ACN is a comprehensive clinical site platform. ACN currently owns and operates six clinical research sites serving patients, leading pharmaceutical sponsors and contract research organizations across three states (California, Nevada and Texas). With a focus on Phase II and Phase III general medicine trials and a demonstrated expertise in enrolling diverse patient populations, ACN services a range of clinical... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
